Elasomeran/tozinameranSevere immune thrombocytopenia: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1910卷 / 1期

关键词：

D O I：

10.1007/s40278-022-17041-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：206 / 206

相关论文

共 50 条

[21] Elasomeran/tozinameranLack of efficacy: 2 case reports
Reactions Weekly, 2023, 1946 (1) : 226 - 226
[22] Elasomeran/tozinameranGeneralised morphoea: 2 case reports
Reactions Weekly, 2022, 1927 (1) : 243 - 243
[23] Elasomeran/tozinameranAcute encephalitis: 2 case reports
Reactions Weekly, 2023, 1956 (1) : 209 - 209
[24] Elasomeran/tozinameranAcute myocarditis: 2 case reports
Reactions Weekly, 2023, 1951 (1) : 141 - 141
[25] Elasomeran/immune-globulinImmune thrombotic thrombocytopenia and pulmonary oedema: case report
Reactions Weekly, 2022, 1901 (1) : 234 - 234
[26] VonoprazanDrug-induced immune thrombocytopenia: 2 case reports
Reactions Weekly, 2018, 1696 (1) : 364 - 364
[27] Multiple drugsDrug induced immune thrombocytopenia: 2 case reports
Reactions Weekly, 2018, 1695 (1) : 261 - 261
[28] Dexamethasone/elasomeran/immune-globulinImmune thrombocytopenia and lack of efficacy: case report
Reactions Weekly, 2022, 1931 (1) : 227 - 227
[29] Elasomeran/tozinameranMinimal change disease: 2 case reports
Reactions Weekly, 2023, 1978 (1) : 165 - 165
[30] Elasomeran/tozinameranThyroid eye disease: 2 case reports
Reactions Weekly, 2023, 1951 (1) : 142 - 142

← 1 2 3 4 5 →